Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).

Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, Boyett JM, Kun L.

J Neurooncol. 2012 Sep;109(3):565-71. doi: 10.1007/s11060-012-0929-x. Epub 2012 Jul 13.

2.

Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).

Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R.

J Clin Oncol. 2005 Jan 20;23(3):525-31.

PMID:
15659498
3.

Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.

Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA.

Pediatr Neurosurg. 1996 Oct;25(4):174-81.

PMID:
9293544
4.

Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.

Slavc I, Schuller E, Czech T, Hainfellner JA, Seidl R, Dieckmann K.

J Neurooncol. 1998 Jun-Jul;38(2-3):213-8.

PMID:
9696374
5.

Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.

Slavc I, Schuller E, Falger J, Günes M, Pillwein K, Czech T, Dietrich W, Rössler K, Dieckmann K, Prayer D, Hainfellner J.

J Neurooncol. 2003 Sep;64(3):239-47.

PMID:
14558599
6.
7.

Neoadjuvant chemotherapy for brain tumors in infants and young children.

Iwama J, Ogiwara H, Kiyotani C, Terashima K, Matsuoka K, Iwafuchi H, Morota N.

J Neurosurg Pediatr. 2015 May;15(5):488-92. doi: 10.3171/2014.11.PEDS14334. Epub 2015 Feb 27.

PMID:
25723725
8.

Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.

Tornesello A, Mastrangelo S, Piciacchia D, Bembo V, Colosimo C, Di Rocco C, Mastrangelo R.

J Neurooncol. 1999;45(2):135-40.

PMID:
10778729
9.

Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.

Friedrich C, Warmuth-Metz M, von Bueren AO, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann RD, Rutkowski S.

J Neurosurg Pediatr. 2015 Mar;15(3):227-35. doi: 10.3171/2014.9.PEDS14213. Epub 2015 Jan 2.

PMID:
25555122
10.

Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.

Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.

Jpn J Clin Oncol. 2008 Jul;38(7):486-92. doi: 10.1093/jjco/hyn049. Epub 2008 Jun 23.

PMID:
18573848
11.

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.

Fouladi M, Gururangan S, Moghrabi A, Phillips P, Gronewold L, Wallace D, Sanford RA, Gajjar A, Kun LE, Heideman R.

Cancer. 2009 Jul 15;115(14):3243-53. doi: 10.1002/cncr.24362.

12.

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.

Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T; Children's Cancer Group.

J Clin Oncol. 2005 Oct 20;23(30):7621-31.

PMID:
16234523
13.

Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.

Gerber NU, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann RD.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):863-71. doi: 10.1016/j.ijrobp.2014.04.017.

PMID:
24969797
14.

Relapse patterns in pediatric embryonal central nervous system tumors.

Perreault S, Lober RM, Carret AS, Zhang G, Hershon L, Décarie JC, Yeom K, Vogel H, Fisher PG, Partap S.

J Neurooncol. 2013 Nov;115(2):209-15. doi: 10.1007/s11060-013-1213-4. Epub 2013 Aug 7.

PMID:
23921420
15.

[Germ cell and embryonal tumors].

Reith W, Mühl-Benninghaus R, Simgen A, Yilmaz U.

Radiologe. 2014 Aug;54(8):772-82. doi: 10.1007/s00117-014-2667-x. German.

PMID:
25119569
16.

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.

Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.

Pediatr Blood Cancer. 2007 Mar;48(3):278-84.

PMID:
16456857
17.
18.

Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.

Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.

Pediatr Blood Cancer. 2004 Jul;43(1):46-54.

PMID:
15170889
19.

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ, Wisoff J.

J Neurosurg. 1998 Apr;88(4):695-703.

PMID:
9525716
20.

[Therapeutic management of central nervous system lymphomas in a single hematological institute].

Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.

Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703. Hungarian.

PMID:
19812012

Supplemental Content

Support Center